| TC | Stat | Stk | Ins | Fil | +d | +w | +m | +q | +h | +y | avg | 
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | -3 | -6 | -12 | 5 | -11 | -29 | -9 | 
| P | %wins | 50 | 0 | 0 | 50 | 0 | 0 | 17 | |||
| S | %ret | 1 | 1 | 1 | 0 | -3 | -17 | -7 | -12 | -32 | -14 | 
| S | %wins | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 
| Filing Date | T Date | Ticker | Issuer | Inc | Sector | Ind | Industry | Owner | oSt | Rel | Title | T | TVal | Price | L | Qty | oc | Own | H | r2y | r1y | r6m | r3m | r6w | r3w | r7d | r3d | f1d | f1w | f1m | f3m | f6m | f1y | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6/16/10 16:21 | 6/15/10 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Bernhardt Charles Thomas III | PA | O | CFO | P | 117 | 0.5920 | 0 | 198 | 177 | D | -16 | -78 | 0 | -19 | -20 | -8 | -3 | -2 | 0 | -3 | -17 | -7 | -12 | -32 | |
| 6/16/10 16:21 | 6/15/10 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Bernhardt Charles Thomas III | PA | O | CFO | S | -52 | 0.5920 | 0 | -88 | -33 | 177 | D | -16 | -78 | 0 | -19 | -20 | -8 | -3 | -2 | 0 | -3 | -17 | -7 | -12 | -32 | 
| 12/8/09 09:39 | 12/7/09 | HEB | Hemispherx Biopharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Bernhardt Charles Thomas III | PA | O | CFO | P | 1 | 0.5629 | 0 | 2 | 3 | 67 | D | -50 | 63 | -77 | -69 | -62 | -40 | -46 | -8 | -6 | -9 | -6 | 17 | -9 | -26 | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |